5 completed, 1 active not recruiting, 1 enrolling by invitation. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 5, Active not recruiting 1, Enrolling by invitation 1 |
Follow Dementia, Vascular: new trials by email Literature Review of Dementia, Vascular trials Research Report on Dementia, Vascular
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy Atorvastatin 40 Mg Oral Tablet, Placebo - Dementia, Mixed, Dementia, Vascular | Phase 4 | Active not recruiting | Monash University | 341 | 2019-09-19 | 2025-05-22 |
| Efficacy of Pain Treatment on Depression in Patients With Dementia Paracetamol, Buprenorphine, Paracetamol placebo - Depression, Pain | Phase 4 | Completed | University of Bergen | 163 | 2014-08-01 | 2017-04-04 |
| Imaging of Brain Amyloid Plaques in the Aging Population Pittsburgh Compound B (C-11 PiB), F-18 FDG, Tau (18-F-AV-1451) - Alzheimer's Disease, Dementia With Lewy Bodies | Phase 4 | Enrolling by invitation | Mayo Clinic | 8000 | 2008-04-01 | 2026-06-23 |
| Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions Cilostazol, Aspirin - Vascular Dementia, Stroke | Phase 4 | Completed | Peking University First Hospital | 200 | 2008-03-01 | 2015-05-06 |
| Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT) hydrocodone/APAP w placebo PRN, hydrocodone/APAP, placebo with hydrocodone/APAP PRN - Alzheimer Disease, Dementia | Phase 4 | Completed | VA Office of Research and Development | 11 | 2007-10-01 | 2015-11-20 |
| A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia Cerebrolysin, 0.9% Saline Solution - Vascular Dementia | Phase 4 | Completed | Ever Neuro Pharma GmbH | 242 | 2006-10-01 | 2024-02-21 |
| Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia donepezil hydrochloride (Aricept) - Vascular Dementia | Phase 4 | Completed | Eisai Inc. | 36 | 2005-09-01 | 2012-05-04 |
Alzheimer Disease (3) · Dementia (3) · Lewy Body Disease (2) · Pain (2) · Agnosia (1) · Cognitive Dysfunction (1) · Dementia, Multi-Infarct (1) · Depression (1) · Frontotemporal Dementia (1) · Frontotemporal Lobar Degeneration (1) · Mixed Dementias (1) · Psychomotor Agitation (1) · Stroke (1)
Arterial Occlusive Diseases (7) · Arteriosclerosis (7) · Brain Diseases (7) · Cardiovascular Diseases (7) · Central Nervous System Diseases (7) · Cerebrovascular Disorders (7) · Intracranial Arterial Diseases (7) · Intracranial Arteriosclerosis (7) · Leukoencephalopathies (7) · Mental Disorders (7) · Nervous System Diseases (7) · Neurocognitive Disorders (7) · Vascular Diseases (7) · Dementia (4) · Neurodegenerative Diseases (3)
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1) · Acetaminophen (1) · Aspirin (1) · Atorvastatin (1) · Buprenorphine (1) · Cilostazol (1) · Donepezil (1) · Saline Solution (1) · Tablets (1) · cerebrolysin (1) · oxycodone-acetaminophen (1) · tau Proteins (1)
Eisai Inc. (1) · Ever Neuro Pharma GmbH (1) · Mayo Clinic (1) · Monash University (1) · Peking University First Hospital (1) · University of Bergen (1) · VA Office of Research and Development (1)
United States (2) · Australia (1) · China (1) · Norway (1) · Philippines (1) · Russia (1)
Andrea Snow, PhD MS BS (1) · Ane Erdal, PhD candidate (1) · Elisabeth Flo, PhD (1) · Huang Yining, MD PhD (1) · Jacqueline Dominguez (1) · Philipp Novak, PhD (1) · Sophia Zoungas, MBBS, FRACP (1) · Val Lowe, M.D. (1)
PMID 20656516, PMID 29487556, PMID 29725986, PMID 33189083, PMID 35833913, PMID 37920607
R01AG011378 (1), U01AG006786 (1)